v3.26.1
Material Agreements (Details) - USD ($)
$ / shares in Units, $ in Thousands
 2 Months Ended 3 Months Ended 6 Months Ended 65 Months Ended 68 Months Ended
Mar. 03, 2026
Aug. 13, 2025
Mar. 27, 2023
Mar. 02, 2023
Oct. 26, 2022
Sep. 26, 2022
Nov. 03, 2020
Oct. 23, 2020
May 21, 2020
Dec. 31, 2020
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Jun. 30, 2026
May 12, 2026
Dec. 31, 2025
Jun. 30, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Warrants issued (in shares) 375,000                                    
Sale of stock, shares committed, aggregate amount $ 5,000                                    
Sale of stock, share commitment, period following effective date (in days) 90 days                                    
Revenues                     $ 13,819 $ 10,003 $ 28,265 $ 18,723          
Assertio Holdings, Inc                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Revenues         $ 6,000                            
Proceeds from collaborators         $ 9,000                            
License and royalty revenue (a)                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Revenues                     1,326 $ 839 $ 6,721 $ 1,629          
Minimum                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Warrant exercise price (in dollars per share) $ 4.00                                    
Commercial exploitation agreement with Indivior                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
License agreement term (in years)                         7 years            
Automatic renewal period of agreement (in years)       1 year                 1 year            
License agreement with Sunovion Pharmaceuticals, Inc milestones                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Aggregate payment               $ 17,000                      
License agreement with Sunovion Pharmaceuticals, Inc milestones | License and royalty revenue (a)                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Revenues                 $ 4,000                    
License agreement with Sunovion Pharmaceuticals, Inc.                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Aggregate payment               22,000                      
License agreement with Sunovion Pharmaceuticals, Inc. upfront                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Aggregate payment               $ 5,000                      
MAM Pangolin Royalty , LLC | Maximum                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Proceeds from sale of future revenue             $ 125,000                        
Zevra And Commave Therapeutics Agreement | License and royalty revenue (a)                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Revenues                     500   $ 5,000            
Common Stock Warrants                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Warrants issued (in shares) 375,000                                   8,850,000
Common Stock Warrants | Minimum                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Warrant exercise price (in dollars per share) $ 4.00                                   $ 0.96
Purchase And Sale Agreement | RTW Investments LP                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Exchange for the purchaser’s payment   $ 75                                  
Revenue sharing percentage   9.50%                                  
Revenue share payments year ten   $ 187,500                                  
Revenue share payments thereafter   $ 225                                  
Capitalized legal fees                     $ 752   $ 752     $ 752   $ 700  
Purchase And Sale Agreement | RTW Investments LP | Minimum                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Revenue sharing percentage   1.00%                                  
Purchase And Sale Agreement | RTW Investments LP | Maximum                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Revenue sharing percentage   7.50%                                  
Monetization Agreement | MAM Pangolin Royalty , LLC                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Proceeds from sale of future revenue             40,000     $ 10,000         $ 50,000 $ 50,000      
Additional proceeds from sale of future revenue             10,000                        
Proceeds from debt, contingent on additional milestones             $ 75,000                        
License & Supply Agreement | Atnahs Pharma UK Limited                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Proceeds from sale of future revenue           $ 3,500                          
License & Supply Agreement | Atnahs Pharma UK Limited, Amended Agreement                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Proceeds from sale of future revenue     $ 2,000                                
Senior Notes | Purchase And Sale Agreement | RTW Investments LP                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Interest rate (as a percent)   13.50%                                  
Oaktree Capital Management LP | Line of Credit                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Credit facility, maximum borrowing capacity                                 $ 150    
Oaktree Capital Management LP | Line of Credit | Tranche A Warrant                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Warrants issued (in shares)                                 230,271    
Warrant exercise price (in dollars per share)                                 $ 4.18    
Oaktree Capital Management LP | Line of Credit | Secured Debt                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Principal amount                                 $ 55,000    
Oaktree Capital Management LP | Line of Credit | Delayed Draw Term Loan (DDTL)                                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                      
Potential increase in available borrowing capacity upon pre determined achievement of milestones                                 $ 95